Scilex (NASDAQ:SCLXW) Shares Up 4.7% – Here’s What Happened

by · The Cerbat Gem

Scilex Holding (NASDAQ:SCLXW – Get Free Report)’s share price traded up 4.7% during trading on Thursday . The stock traded as high as $0.22 and last traded at $0.22. 220 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 12,979 shares. The stock had previously closed at $0.21.

Scilex Stock Performance

The business has a fifty day moving average price of $0.29 and a two-hundred day moving average price of $0.32.

Scilex Company Profile

(Get Free Report)

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

See Also